Overview

Sphenopalatine Ganglion Block for Post-Dural Puncture Headache in Orthopedic Patients

Status:
Not yet recruiting
Trial end date:
2021-05-20
Target enrollment:
0
Participant gender:
All
Summary
The aim of this study is to assess the efficacy, onset and duration of analgesia of sphenopalatine ganglion bock (SPGB) using lidocaine 4% with adrenaline as a treatment of postoperative Post dural puncture headache (PDPH) of orthopedic patients after lower limbs surgeries.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Tanta University
Criteria
Inclusion Criteria:

- Admitted to the orthopedic department

- Complaining of criteria of severe post-dural puncture headache within 7 days following
subarachnoid block used for lower limbs surgeries.

- American Society of Anesthesiologists (ASA) physical status I and II.

Exclusion Criteria:

- Patient refusal or uncooperative.

- Patients with uncontrollable hypertension.

- Patient with known coagulopathy.

- Patient with nasal septal deviation, polyp, history of nasal bleeding.

- Patient with allergy to local anesthetics

- American Society of Anesthesiologists physical status>2.